Lisi S.A.

$ 67.50 0.15 %

Lisi S.A. is a global provider of specialized assembly and component solutions, primarily serving the aerospace, automotive, and medical sectors. The company organizes its operations into three distinct divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace specializes in advanced aircraft components, including titanium fasteners, lightning protection, safety locking mechanisms, and fuse pins. Their contributions to the LEAP engine encompass compressor blades, struts, and composite fan blade leading edges. They also produce air intake lipskins for Airbus aircraft, semi-machined gears for power transmission, stator vanes, and satellite antenna mounting brackets for both airplanes and helicopters. LISI Automotive delivers a broad spectrum of fastening and component solutions for vehicles. This includes guide pins, electric parking brake elements, complete braking systems, and direct engine injection parts. They supply various fasteners like screws, nuts, and specialized clips for interior and exterior trim, alongside components for seat belt mechanisms, motor systems, and safety applications. The division also focuses on assembly optimization, offering cable ducts, battery fastening systems, intricate power transmission parts, and standard automotive fasteners. Furthermore, they provide clipped fastening solutions for both internal and external cladding, specialized fasteners for tubes and cables, and products designed to reduce weight and streamline assembly processes. Their portfolio extends to critical components for braking, fluid management, seat adjustment, and interior safety systems. LISI Medical is involved in the complete lifecycle of medical device development, from initial design and modeling through prototyping, pre-series production, material selection, process validation, and inventory management. They manufacture a range of orthopedic reconstruction implants for shoulders, hips, knees, and extremities, along with associated surgical instruments. The division also produces various surgical tools, such as blades, scissors, staplers, and pliers. Additionally, they provide spinal and trauma implants, including connectors, screws, cages, plates, and prostheses, specifically designed for treating trauma and facilitating osteosynthesis. Established in 1777, the company, originally known as GFI Industries, adopted the name LISI S.A. in 2002. Headquartered in Belfort, France, it operates as a subsidiary of Compagnie Industrielle De Delle S.A.

CEO: Emmanuel Viellard - https://www.lisi-group.com

Price objectif

-

Recommandation

-

DCF

$ 43.27

Loading data...

FII.PA vs S&P500

Loading data...

No data available.

Quick ratio

1.04

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

49.63

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

1.36

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

13.55 %

reflects reasonable profitability, showing good use of equity.

ROIC

6.58 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

9.93

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.46

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

1.89

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

12.81 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
9 indicates good financial health
Altman score
4.28 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.54 indicates that the company has a moderate ability to cover its short-term debts with its cash
Debt Ratio
0.24 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.